GARDENA, Calif.–(BUSINESS WIRE)–Daiwa Health Developmenta leading provider of natural health products, announces that it will be a partner in an upcoming webinar for a renowned author and physician on the topic of Proprietary Bacillopeptidase F (BFPB) Blend and its role in metabolic disorders.

The webinar, scheduled for Wednesday, June 22 at 3:00 p.m. EDT, will feature Dr. Fred Pescatore, MD MPH as a guest speaker. He is a Manhattan-based physician and traditionally trained internist specializing in nutritional medicine. His best-selling book, “The Hamptons Diet,” made him a world-renowned expert on health, nutrition, and weight loss.

The webinar will be hosted and presented by Holistic Primary Care (HPC), a newsletter sent to over 21,000 physicians and other healthcare professionals. During the webinar, the Californian company will present its new product, Daiwa Brain Healthand provide free samples of its best-selling products, Plasmanex1, Daiwa Brain Healthand Daiwa Gastro Health to all participants.

“We are thrilled to be able to showcase our products to such a large and influential group of people,” said Nori Shirai, Executive Director of Daiwa Pharmaceutical Co., Ltd.the parent company of Daiwa Health Development.

“This is a great opportunity for us to show the effectiveness of our products and reach a new audience of potential customers.”

Daiwa Brain Health is based on several scientific studies that demonstrate the effectiveness of plasmalogen, a type of phospholipid found in high concentrations in the brain, to reduce cognitive decline and improve memory.

Plasmanex1 contains Proprietary Bacillopeptidase F (BFPB) Blend as an active ingredient. BFBP is a natural soy peptide enzyme extracted using a proprietary fermentation process. The enzyme is isolated from natto, a popular fermented soy product in Japan, to form a unique molecule that has been shown in scientific research to support healthy blood circulation.

Shirai added that “Daiwa’s products are based on cutting-edge science and are backed by years of clinical research. We believe our products have the potential to change the lives of those who use them for the better, and we are thrilled to be able to share them with the world.”

Guests will include medical professional subscribers and retail customers in the Daiwa database. The webinar is free, but registration is required. To register for the webinar, go to Daiwa website.

About Daiwa Health Development

Daiwa Health Development is a California-based company specializing in natural health products. Its mission is to provide innovative and effective health solutions that improve the quality of life of its customers. The company’s products are based on cutting edge scientific research and are manufactured in GMP certified facilities in the United States. Daiwa Health Development is the US subsidiary of Daiwa Pharmaceutical Co., Ltd, a privately held Japanese company with decades of experience in the research, development and manufacturing of health products.

**These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure or prevent any disease. Daiwa Health Development does not provide medical advice, diagnosis or treatment.